Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 8, 2023. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 88
- +19 vs. Q2 2021
- Portfolio value
- $1.25B
- +$166.2M (+15.4%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UTHRUnited Therapeutics Corp | COM | 444,471 | $82.0M | 6.6% | +1,526+0.3% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 445,203 | $71.0M | 5.7% | +203,429+84.1% | Added | History |
| CYHCommunity Health Systems Inc | COM | 5,988,163 | $70.1M | 5.6% | +2,166,434+56.7% | Added | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 634,670 | $69.5M | 5.6% | −32,068−4.8% | Reduced | History |
| XLRNAcceleron Pharma Inc | COM | 349,494 | $60.1M | 4.8% | +14,449+4.3% | Added | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 11,604,990 | $59.2M | 4.8% | −5,064,481−30.4% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 890,808 | $53.5M | 4.3% | −94,914−9.6% | Reduced | History |
| AVTRAvantor, Inc. | COM | 1,292,014 | $52.8M | 4.2% | +317,377+32.6% | Added | History |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 689,501 | $51.5M | 4.1% | −83,979−10.9% | Reduced | – |
| DHRDanaher Corp | Stock | 147,938 | $45.1M | 3.6% | −56,767−27.7% | Reduced | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 6,849,834 | $36.6M | 2.9% | +1,225,109+21.8% | Added | History |
| LHLabcorp Holdings Inc. | COM NEW | 128,311 | $36.1M | 2.9% | +128,311 | New | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 3,554,804 | $34.6M | 2.8% | −249,601−6.6% | Reduced | History |
| NVSTEnvista Holdings Corp | COM | 810,881 | $33.9M | 2.7% | +154,783+23.6% | Added | History |
| MCKMcKesson Corp | Stock | 161,708 | $32.3M | 2.6% | +86,708+115.6% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 464,801 | $27.8M | 2.2% | −13,527−2.8% | Reduced | History |
| CTLTCatalent, Inc. | COM | 184,299 | $24.5M | 2.0% | +184,299 | New | History |
| ICLRIcon PLC | COM | 71,911 | $18.8M | 1.5% | +71,911 | New | History |
| MASIMasimo Corp | COM | 67,000 | $18.1M | 1.5% | +67,000 | New | History |
| OCDXOrtho Clinical Diagnostics Holdings plc | ORD SHS | 914,986 | $16.9M | 1.4% | −479,298−34.4% | Reduced | History |
| RCMR1 RCM Holdco Inc. | COM | 764,780 | $16.8M | 1.4% | −5,220−0.7% | Reduced | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 327,810 | $16.1M | 1.3% | +252,810+337.1% | Added | History |
| FATEFate Therapeutics Inc | COM | 260,895 | $15.5M | 1.2% | −85,452−24.7% | Reduced | History |
| GSKGSK plc | SPONSORED ADR | 401,654 | $15.4M | 1.2% | +288,975+256.5% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 450,501 | $15.1M | 1.2% | +8,501+1.9% | Added | History |
| GHGuardant Health, Inc. | COM | 100,361 | $12.5M | 1.0% | +98,552+5,447.9% | Added | History |
| NTRANatera, Inc. | COM | 112,189 | $12.5M | 1.0% | +102,875+1,104.5% | Added | History |
| SNYSanofi | SPONSORED ADR | 259,128 | $12.5M | 1.0% | +259,128 | New | History |
| ELVElevance Health, Inc. | Stock | 31,628 | $11.8M | 0.9% | +21,496+212.2% | Added | History |
| ZGNXZogenix, Inc. | COM NEW | 774,591 | $11.8M | 0.9% | +278,731+56.2% | Added | History |
| Taro Pharmaceutical Inds LtdM8737E108 | SHS | 179,366 | $11.4M | 0.9% | +5,117+2.9% | Added | – |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 59,233 | $11.2M | 0.9% | +8,097+15.8% | Added | History |
| EXELExelixis, Inc. | COM | 516,307 | $10.9M | 0.9% | +336,307+186.8% | Added | History |
| MGLNMagellan Health Inc | COM NEW | 104,700 | $9.90M | 0.8% | 00.0% | Unchanged | History |
| HUMHumana Inc | Stock | 24,083 | $9.39M | 0.8% | +5,427+29.1% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 38,366 | $9.31M | 0.7% | +30,052+361.5% | Added | History |
| CNCCentene Corp | Stock | 141,107 | $8.79M | 0.7% | +73,107+107.5% | Added | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 230,744 | $8.60M | 0.7% | +113,282+96.4% | Added | History |
| RVTYRevvity, Inc. | COM | 47,081 | $8.16M | 0.7% | +47,081 | New | History |
| NSTGNS Wind Down Co., Inc. | COM | 168,668 | $8.10M | 0.6% | +168,668 | New | History |
| HQYHealthequity, Inc. | COM | 114,378 | $7.41M | 0.6% | −83,122−42.1% | Reduced | History |
| QGENQiagen N.V. | SHS NEW | 143,109 | $7.40M | 0.6% | −507,926−78.0% | Reduced | History |
| IRTCiRhythm Holdings, Inc. | COM | 113,854 | $6.67M | 0.5% | +113,854 | New | History |
| GOCOGoHealth, Inc. | COM CL A | 1,261,723 | $6.35M | 0.5% | +1,192,824+1,731.3% | Added | History |
| HRCHill-Rom Holdings, Inc. | COM | 30,000 | $4.50M | 0.4% | +30,000 | New | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 872,694 | $4.20M | 0.3% | +643,405+280.6% | Added | History |
| ARK Innovation ETF00214Q104 | ETF | 35,000 | $3.87M | 0.3% | −50,000−58.8% | Reduced | – |
| SRGASurgalign Holdings, Inc. | COM | 3,508,536 | $3.82M | 0.3% | −373,560−9.6% | Reduced | History |
| DXCMDexcom Inc | COM | 6,401 | $3.50M | 0.3% | −3,124−32.8% | Reduced | History |
| SIBNSI-BONE, Inc. | COM | 150,000 | $3.21M | 0.3% | +150,000 | New | History |
| ISRGIntuitive Surgical Inc | COM NEW | 3,145 | $3.13M | 0.3% | +562+21.8% | Added | History |
| EVHEvolent Health, Inc. | CL A | 100,170 | $3.11M | 0.2% | +100,170 | New | History |
| KRTXKaruna Therapeutics, Inc. | COM | 25,000 | $3.06M | 0.2% | +25,000 | New | History |
| AAgilent Technologies, Inc. | COM | 18,660 | $2.94M | 0.2% | +3,399+22.3% | Added | History |
| PBYIPuma Biotechnology, Inc. | COM | 397,940 | $2.79M | 0.2% | +397,940 | New | History |
| VRDNViridian Therapeutics, Inc. | COM | 160,000 | $2.63M | 0.2% | +160,000 | New | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 398,074 | $2.61M | 0.2% | −75,000−15.9% | Reduced | History |
| LQDALiquidia Corp | COM NEW | 929,049 | $2.56M | 0.2% | −50,000−5.1% | Reduced | History |
| MORFMorphic Holding, Inc. | COM | 43,600 | $2.47M | 0.2% | +43,600 | New | History |
| OMOutset Medical, Inc. | COM | 47,500 | $2.35M | 0.2% | −59,800−55.7% | Reduced | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 444,887 | $2.30M | 0.2% | +444,887 | New | History |
| HSTMHealthstream Inc | COM | 77,812 | $2.22M | 0.2% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | 899,569 | $2.18M | 0.2% | +899,569 | New | History |
| ANABAnaptysbio, Inc | COM | 78,054 | $2.12M | 0.2% | +78,054 | New | History |
| TECXTectonic Therapeutic, Inc. | COM | 359,480 | $2.01M | 0.2% | +359,480 | New | History |
| GOSSGossamer Bio, Inc. | COM | 149,910 | $1.88M | 0.2% | +149,910 | New | History |
| MYOMyomo, Inc. | COM NEW | 150,000 | $1.78M | 0.1% | +150,000 | New | History |
| ARGXArgenx SE | SPONSORED ADR | 5,746 | $1.74M | 0.1% | +5,746 | New | History |
| MRTXMirati Therapeutics, Inc. | COM | 9,355 | $1.65M | 0.1% | +9,355 | New | History |
| IQVIQVIA Holdings Inc. | Stock | 6,790 | $1.63M | 0.1% | +1,078+18.9% | Added | History |
| LogicBio Therapeutics, Inc.54142F102 | COM | 349,919 | $1.60M | 0.1% | +349,919 | New | – |
| ACIUAC Immune SA | SHS | 221,749 | $1.49M | 0.1% | +221,749 | New | History |
| DNTHDianthus Therapeutics, Inc. | COM | 198,879 | $1.45M | 0.1% | +198,879 | New | History |
| ORTXOrchard Therapeutics plc | ADS | 569,581 | $1.31M | 0.1% | +569,581 | New | History |
| AKYAAkoya Biosciences, Inc. | COM | 91,568 | $1.28M | 0.1% | +91,568 | New | History |
| RGENRepligen Corp | COM | 4,402 | $1.27M | 0.1% | +710+19.2% | Added | History |
| ASMBAssembly Biosciences, Inc. | COM | 350,000 | $1.22M | 0.1% | +350,000 | New | History |
| HSKAHeska Corp | COM RESTRC NEW | 4,525 | $1.17M | 0.1% | +1,113+32.6% | Added | History |
| AMNAmn Healthcare Services Inc | COM | 10,000 | $1.15M | 0.1% | −149,101−93.7% | Reduced | History |
| KRSAKorsana Biosciences, Inc. | COM | 371,955 | $1.14M | 0.1% | +371,955 | New | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 300,000 | $933.0K | 0.1% | +300,000 | New | History |
| ENSGEnsign Group, Inc | COM | 10,397 | $779.2K | 0.1% | +1,424+15.9% | Added | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 114,008 | $704.6K | 0.1% | +114,008 | New | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 113,597 | $648.6K | 0.1% | +113,597 | New | History |
| Teligent, Inc.87960W203 | COM NEW | 1,069,465 | $426.7K | <0.1% | −1,430,795−57.2% | Reduced | – |
| CCRNCross Country Healthcare Inc | COM | 20,000 | $424.8K | <0.1% | −10,810−35.1% | Reduced | History |
| FSTXF-star Therapeutics, Inc. | COM | 49,933 | $365.5K | <0.1% | −50,067−50.1% | Reduced | History |
| KRROKorro Bio, Inc. | COM | 30,000 | $211.8K | <0.1% | +30,000 | New | History |
Options (16)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| GSKGSK plc | SPONSORED ADR | – | $57.5M |
| SPYSPDR S&P 500 ETF Trust | ETF | $42.9M | – |
| VRTXVertex Pharmaceuticals Inc | Stock | – | $31.4M |
| AZNAstraZeneca PLC | SPONSORED ADR | – | $15.6M |
| CYHCommunity Health Systems Inc | COM | – | $12.6M |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $9.37M |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | – | $7.67M |
| EDITEditas Medicine, Inc. | COM | $2.05M | $3.70M |
| HRCHill-Rom Holdings, Inc. | COM | – | $4.41M |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $4.17M |
| MRKMerck & Co., Inc. | Stock | – | $3.66M |
| NVAXNovavax Inc | COM NEW | – | $2.07M |
| ACADAcadia Pharmaceuticals Inc | COM | – | $1.41M |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | – | $635.4K |
| KRROKorro Bio, Inc. | COM | $479.4K | – |
| FBRXForte Biosciences, Inc. | COM | $209.7K | – |
Sold out since Q2 2021 (15)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| OGNOrganon & Co. | Stock | 699,696 | $21.2M | 2.0% | History |
| OMCLOmnicell, Inc. | COM | 98,366 | $14.9M | 1.4% | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 54,500 | $11.0M | 1.0% | History |
| CICigna Group | Stock | 41,745 | $9.90M | 0.9% | History |
| OPCHOption Care Health, Inc. | COM NEW | 289,297 | $6.33M | 0.6% | History |
| Affimed N VN01045108 | COM | 566,942 | $4.82M | 0.4% | – |
| CGEMCullinan Therapeutics, Inc. | COM | 163,880 | $4.22M | 0.4% | History |
| KDMNKadmon Holdings, Inc. | COM | 894,995 | $3.46M | 0.3% | History |
| XENTIntersect ENT, Inc. | COM | 175,389 | $3.00M | 0.3% | History |
| IPSCCentury Therapeutics, Inc. | COM | 100,901 | $2.96M | 0.3% | History |
| TGTXTG Therapeutics, Inc. | COM | 69,760 | $2.71M | 0.3% | History |
| OCULOcular Therapeutix, Inc | COM | 150,000 | $2.13M | 0.2% | History |
| Alpha Healthcare Acquistn Co020751103 | CL A | 205,026 | $2.09M | 0.2% | – |
| MCRBSeres Therapeutics, Inc. | COM | 59,560 | $1.42M | 0.1% | History |
| IMVTImmunovant, Inc. | COM | 110,183 | $1.16M | 0.1% | History |